Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and tolerability of an
investigational drug for the treatment of manic episodes of bipolar disorder. The
investigational drug will be given as additional therapy to one of the five following
medications: risperidone, olanzapine, quetiapine, ziprasidone, or aripiprazole. These
medications are already FDA (Food and Drug Administration)-approved treatments for mania.